The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Göran Jönsson receives the Göran Gustafsson's prize in medicine for groundbreaking research in immunotherapy in cancer

Photo Göran Jönsson, professor at Lund University
Göran Jönsson, Professor in molecular oncology at Lund University. Photo: Tove Smeds

Congratulations to Göran Jönsson who receives this year's Göran Gustafsson Prize in medicine.
The prize is awarded by the Royal Academy of Sciences and is awarded to younger researchers who have achieved great success in their field.

Göran Jönsson, professor in molecular oncology at Lund University, receives the award "for his pioneering work in describing the genetic and molecular landscape, as well as the importance of tertiary lymphoid structures, in melanoma".

The research group were able to show that specific clusters of B cells in melanoma tumors, so-called tertiary lymphoid structures, are related to prognosis and how the patient responds to treatment. This finding might explain why some patients with malignant melanoma respond better to immunotherapy than others.

The Göran Gustafsson Prize is a research grant of 5.1 million SEK for a period of 3 years, and a personal prize of 250,000 SEK.

Link to press release from The Royal Academy of Science (SWE)

Link to article published by Tove Smeds 4 March 2022 (SWE)